Hexagon Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $802K | Buy |
|
|||||
|
2025
Q2 | $810K | Sell |
|
|||||
|
2025
Q1 | $1.09M | Buy |
|
|||||
|
2024
Q4 | $977K | Buy |
|
|||||
|
2024
Q3 | $818K | Buy |
|
|||||
|
2024
Q2 | $487K | Sell |
|
|||||
|
2024
Q1 | $850K | Buy |
|
|||||
|
2023
Q4 | $720K | Buy |
|
|||||
|
2023
Q3 | $585K | Buy |
|
|||||
|
2023
Q2 | $588K | Buy |
|
|||||
|
2023
Q1 | $604K | Buy |
|
|||||
|
2022
Q4 | $619K | Sell |
|
|||||
|
2022
Q3 | $688K | Buy |
|
|||||
|
2022
Q2 | $593K | Sell |
|
|||||
|
2022
Q1 | $597K | Sell |
|
|||||
|
2021
Q4 | $545K | Buy |
|
|||||
|
2021
Q3 | $400K | Buy |
|
|||||
|
2021
Q2 | $434K | Buy |
|
|||||
|
2021
Q1 | $369K | Buy |
|
|||||
|
2020
Q4 | $344K | Buy |
|
|||||
|
2020
Q3 | $306K | Buy |
|